These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39195845)

  • 1. Deprescribing NSAIDs: The Potential Role of Community Pharmacists.
    Amedi D; Gazerani P
    Pharmacy (Basel); 2024 Jul; 12(4):. PubMed ID: 39195845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes.
    El-Dahiyat F; Jairoun AA; Al-Hemyari SS; Shahwan M; Hassan N; Jairoun S; Jaber AAS
    Int J Pharm Pract; 2023 Jun; 31(4):387-395. PubMed ID: 37116892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing community pharmacists' attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland.
    Heinrich CH; Donovan MD
    Int J Pharm Pract; 2022 Jan; 30(1):28-35. PubMed ID: 34998277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
    Lukacena KM; Keck JW; Freeman PR; Harrington NG; Huffmyer MJ; Moga DC
    Ther Adv Drug Saf; 2022; 13():20420986221116465. PubMed ID: 36003624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
    Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
    Sanyal C; Turner JP; Martin P; Tannenbaum C
    J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Qatar community pharmacists' competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDs.
    Owusu YB; Elkhalifa WH; Awaisu A; Kheir N
    Saudi Pharm J; 2022 Oct; 30(10):1396-1404. PubMed ID: 36387344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.
    Lüthold RV; Cateau D; Jenkinson SP; Streit S; Jungo KT
    BMC Health Serv Res; 2024 Jul; 24(1):849. PubMed ID: 39061037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pharmacists in deprescribing benzodiazepines: A scoping review.
    Ashkanani FZ; Rathbone AP; Lindsey L
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100328. PubMed ID: 37743854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
    Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
    J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
    Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
    Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the community pharmacists' performance in the screening of non-steroidal anti-inflmmatory drugs risks in Saudi Arabia.
    Malebari AM; Khayyat AN; Mahdali RA; Alamoudi JS; Alsayed BY; Alrasheed SA
    Saudi Med J; 2020 Aug; 41(8):849-857. PubMed ID: 32789426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the knowledge, practices, and attitudes of community pharmacists towards adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a cross-sectional study.
    Barakat HE; Aziz CN; Abougalambou SSI
    J Pharm Policy Pract; 2023 Nov; 16(1):132. PubMed ID: 37915076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' naloxone services beyond community pharmacy settings: A systematic review.
    Rawal S; Osae SP; Cobran EK; Albert A; Young HN
    Res Social Adm Pharm; 2023 Feb; 19(2):243-265. PubMed ID: 36156267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Patients' Attitudes Toward Deprescribing and Their Perception of Pharmacist Involvement in a European Country: A Cross-Sectional Study.
    Bužančić I; Dragović P; Pejaković TI; Markulin L; Ortner-Hadžiabdić M
    Patient Prefer Adherence; 2021; 15():2197-2208. PubMed ID: 34588769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I Think Deprescribing as a Whole Is a Gap!": A Qualitative Study of Student Pharmacist Perceptions about Deprescribing.
    Springer SP; Cernasev A; Barenie RE; Axon DR; Scott D
    Geriatrics (Basel); 2022 Jun; 7(3):. PubMed ID: 35735765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' perceptions on providing fall prevention services: a mixed-methods study.
    Gemmeke M; Koster ES; Rodijk EA; Taxis K; Bouvy ML
    Int J Clin Pharm; 2021 Dec; 43(6):1533-1545. PubMed ID: 34121152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups.
    Scott D; Cernasev A; Barenie RE; Springer SP; Axon DR
    Clin Pract; 2023 Mar; 13(2):442-453. PubMed ID: 36961065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.